Pemazyre
Tablet
Compare
|
EU/1/21/1535/003-004
Authorised: 26/03/2021
Incyte Biosciences Distribution B.V.
|
SPC
PIL
IPAR
|
Pemazyre
Tablet
Compare
|
EU/1/21/1535/005-006
Authorised: 26/03/2021
Incyte Biosciences Distribution B.V.
|
SPC
PIL
IPAR
|
Pemetrexed 25 mg/ml concentrate for solution for infusion
Concentrate for solution for infusion
Compare
|
PA1082/004/001
Authorised: 19/01/2018
BioOrganics BV
|
SPC
PIL
|
Pemetrexed Accord
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1071/001
Authorised: 18/01/2016
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
|
Pemetrexed Accord
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1071/002
Authorised: 18/01/2016
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
|
Pemetrexed Accord
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1071/003
Authorised: 18/01/2016
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
|
Pemetrexed Accord
Concentrate for solution for infusion
Compare
|
EU/1/15/1071/004-007
Authorised: 18/01/2016
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
|
Pemetrexed Baxter
Powder for concentrate for solution for infusion
Compare
|
EU/1/22/1705/001
Authorised: 09/12/2022
Baxter Holding B.V.
|
SPC
PIL
IPAR
|
Pemetrexed Baxter
Powder for concentrate for solution for infusion
Compare
|
EU/1/22/1705/002
Authorised: 09/12/2022
Baxter Holding B.V.
|
SPC
PIL
IPAR
|
Pemetrexed Clonmel 25 mg/ml concentrate for solution for infusion
Concentrate for solution for infusion
Compare
|
PA0126/270/001
Authorised: 05/02/2016
Clonmel Healthcare Ltd
|
SPC
PIL
|
Pemetrexed EVER Pharma 25 mg/ml concentrate for solution for infusion
Concentrate for solution for infusion
Compare
|
PA1774/005/001
Authorised: 08/01/2021
EVER Valinject GmbH
|
SPC
PIL
|
Pemetrexed Fresenius Kabi
Concentrate for solution for infusion
Compare
|
EU/1/16/1115/001
Authorised: 22/07/2016
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
|
Pemetrexed Fresenius Kabi
Concentrate for solution for infusion
Compare
|
EU/1/16/1115/002
Authorised: 22/07/2016
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
|
Pemetrexed Fresenius Kabi
Concentrate for solution for infusion
Compare
|
EU/1/16/1115/003-005
Authorised: 11/02/2020
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
|
Pemetrexed Hospira
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1057/001
Authorised: 20/11/2015
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Pemetrexed Hospira
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1057/002
Authorised: 20/11/2015
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Pemetrexed Hospira
Powder for concentrate for solution for infusion
Compare
|
EU/1/15/1057/003
Authorised: 20/11/2015
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Pemetrexed Hospira
Concentrate for solution for infusion
Compare
|
EU/1/15/1057/004-006
Authorised: 30/09/2020
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Pemetrexed Hospira Limited
Powder for concentrate for solution for infusion
Compare
|
EU/1/17/1183/001
Authorised: 24/04/2017
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Pemetrexed Hospira Limited
Powder for concentrate for solution for infusion
Compare
|
EU/1/17/1183/002
Authorised: 24/04/2017
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|